Inventor · disambiguated record
Albert Zlotnik
Also filed as: ZLOTNIK ALBERT
43 granted patents·35 pending applications·1,216 citations·filing 1994–2019
98Inventor score
Top patents by PatentIndex Score
78 records- 0198US7025962B1Mammalian cell surface antigens; related reagentsSCHERING CORP·Filed 2000·Granted Apr 11, 2006·346 cites·8 claims
- 0297US8541421B2Methods of enhancing sweet taste of compositions using substituted thieno{2,3-D}pyrimidinesTACHDJIAN CATHERINE·Filed 2011·Granted Sep 24, 2013·114 cites·15 claims
- 0397US6111090AMammalian cell surface antigens; related reagentsSCHERING CORP·Filed 1997·Granted Aug 29, 2000·351 cites·36 claims
- 0496US8633186B2Modulation of chemosensory receptors and ligands associated therewithTACHDJIAN CATHERINE·Filed 2008·Granted Jan 21, 2014·67 cites·16 claims
- 0596US7928111B2Compounds including substituted thienopyrimidinone derivatives as ligands for modulating chemosensory receptorsSENOMYX INC·Filed 2007·Granted Apr 19, 2011·60 cites·14 claims
- 0694US9603848B2Modulation of chemosensory receptors and ligands associated therewithSERVANT GUY·Filed 2007·Granted Mar 28, 2017·24 cites·48 claims
- 0793US9181276B2Modulation of chemosensory receptors and ligands associated therewithSENOMYX INC·Filed 2013·Granted Nov 10, 2015·26 cites·35 claims
- 0893US6949243B1Methods of inhibiting metastasisSCHERING CORP·Filed 2000·Granted Sep 27, 2005·31 cites·10 claims
- 0988US7932058B2Rationale, methods, and assays for identifying human and non-human primate taste specific genes and use thereof in taste modulator and therapeutic screening assaysSENOMYX INC·Filed 2008·Granted Apr 26, 2011·7 cites·4 claims
- 1088US6723520B2Antibodies that bind chemokine teckSCHERING CORP·Filed 2002·Granted Apr 20, 2004·11 cites·22 claims
- 1185US7279460B2Chemokine TECK polypeptidesSCHERING CORP·Filed 2004·Granted Oct 9, 2007·7 cites·7 claims
- 1284US7431924B2Methods of treating inflammation using mammalian CX3C chemokine antibodiesSCHERING CORP·Filed 2006·Granted Oct 7, 2008·7 cites·19 claims
- 1383US7585502B2Mammalian CX3C chemokine antibodiesSCHERING CORP·Filed 2008·Granted Sep 8, 2009·4 cites·19 claims
- 1483US7521045B2Methods of inhibiting metastasisSCHERING CORP·Filed 2005·Granted Apr 21, 2009·3 cites·30 claims
- 1581US6645491B1Method for treating inflammatory conditions using an antibody to MIP-3αSCHERING CORP·Filed 2000·Granted Nov 11, 2003·14 cites·22 claims
- 1681US5837232AUse of an interleukin-10 antagonist to treat a B cell mediated autoimmune disorderSCHERING CORP·Filed 1995·Granted Nov 17, 1998·30 cites·7 claims
- 1780US7115379B1Anti-mammalian CX3C cytokine antibodiesSCHERING CORP·Filed 2003·Granted Oct 3, 2006·24 cites·23 claims
- 1879US7785804B2Mammalian CX3C chemokine antibodiesSCHERING CORP·Filed 2009·Granted Aug 31, 2010·2 cites·23 claims
- 1979US6566503B2Mammalian CX3C chemokineSCHERING CORP·Filed 2001·Granted May 20, 2003·11 cites·5 claims
- 2078US8669066B2Rationale, methods, and assays for identifying human and non-human primate taste specific genes and use thereof in taste modulator and therapeutic screening assaysMOYER BRYAN·Filed 2011·Granted Mar 11, 2014·3 cites·9 claims
- 2177US7276238B2Methods for using chemokine teckSCHERING CORP·Filed 2004·Granted Oct 2, 2007·2 cites·20 claims
- 2277US7101987B2CCL27 polypeptidesSCHERING CORP·Filed 2002·Granted Sep 5, 2006·6 cites·9 claims
- 2375US6737252B27 transmembrane receptor family member BLRXSCHERING CORP·Filed 2001·Granted May 18, 2004·4 cites·16 claims
- 2475US2010068763A1Mammalian chemokines; receptors; reagents; usesSCHERING CORP CANJI INC·Filed 2009·Application pending·0 cites
- 2574US2009175877A1Methods of inhibiting metastasisSCHERING CORP·Filed 2009·Application pending·0 cites
- 2674US2015064192A1Mammalian cell surface antigens; related reagentsMERCK SHARP & DOHME·Filed 2014·Application pending·0 cites
- 2770US2008107643A1Mammalian chemokines; receptors; reagents; usesSCHERING CORP CANJI INC·Filed 2007·Application pending·0 cites
- 2870US2009191629A1Mammalian chemokine reagentsSCHERING CORP·Filed 2009·Application pending·0 cites
- 2968US6824781B2Method of impairing movement of a CLA + memeory T-cell within or to the skin of a mammal by administering a CTACK antagonistSCHERING CORP·Filed 2001·Granted Nov 30, 2004·2 cites·13 claims
- 3067US2006135756A1Mammalian cell surface antigens; related reagentsSCHERING CORP·Filed 2006·Application pending·0 cites
- 3166US7307146B2Dnaxccr10SCHERING CORP·Filed 2006·Granted Dec 11, 2007·0 cites·7 claims
- 3266US2008044835A1Mammalian chemokine reagentsWANG WEI·Filed 2007·Application pending·0 cites
- 3365US10191050B2Rationale, methods, and assays for identifying human and non-human primate taste specific genes and use thereof in taste modulator and therapeutic screening assaysSENOMYX INC·Filed 2017·Granted Jan 29, 2019·0 cites·4 claims
- 3464US2013123200A1Mammalian cell surface antigens; related reagentsMERCK SHARP & DOHME·Filed 2013·Application pending·0 cites
- 3564US2012094937A1Mammalian cell surface antigens; related reagentsGORMAN DANIEL M·Filed 2011·Application pending·0 cites
- 3662US8119786B2Nucleic acids encoding CCL27VICARI ALAIN·Filed 2009·Granted Feb 21, 2012·0 cites·11 claims
- 3762US2004203080A17 transmembrane receptor family member BLRxFiled 2004·Application pending·0 cites
- 3861US9139867B2Rationale, methods, and assays for identifying human and non-human primate taste specific genes and use thereof in taste modulator and therapeutic screening assaysSENOMYX INC·Filed 2014·Granted Sep 22, 2015·0 cites·9 claims
- 3960US9739776B2Rationale, methods, and assays for identifying human and non-human primate taste specific genes and use thereof in taste modulator and therapeutic screening assaysSENOMYX INC·Filed 2015·Granted Aug 22, 2017·0 cites·13 claims
- 4060US8343492B2Method for blocking binding of CX3C chemokines using CX3C chemokine antibodiesSCHERING CORP·Filed 2012·Granted Jan 1, 2013·0 cites·6 claims
- 4160US7601815B2Anti-CCL27 antibodiesSCHERING CORP·Filed 2006·Granted Oct 13, 2009·0 cites·22 claims
- 4260US5833976AUse of interleukin-10 (IL-10) to treat endotoxin- or superantigen-induced toxicitySCHERING CORP·Filed 1995·Granted Nov 10, 1998·9 cites·25 claims
- 4357US5858707APurified mammalian nucleobase permeases; nucleic acids; antibodiesSCHERING CORP·Filed 1996·Granted Jan 12, 1999·10 cites·25 claims
- 4457US5837293AUse of interleukin-10 analogs for antagonists to treat endotoxin- or superantigen-induced toxicitySCHERING CORP·Filed 1995·Granted Nov 17, 1998·9 cites·18 claims
- 4556US6548654B1DNA encoding mammalian CX3C chemokine genesSCHERING CORP·Filed 1996·Granted Apr 15, 2003·13 cites·17 claims
- 4656US2016368995A1Identification of cxcr8, a novel chemokine receptorTHE REGENTS OF THE UNIV OF CALIFORINIA·Filed 2014·Application pending·0 cites
- 4756US2008306076A1Modulation of chemosensory receptors and ligands associated therewithSENOMYX INC·Filed 2007·Application pending·0 cites
- 4856US2004253606A1Methods of detecting soft tissue sarcoma, compositions and methods of screening for soft tissue sarcoma modulatorsPROTEIN DESIGN LABS INC·Filed 2003·Application pending·0 cites
- 4954US2004042998A1Chemokine uses; compositions; methodsFiled 2003·Application pending·0 cites
- 5053US2005002939A1Tumor killing/tumor regression using CXCR4 antagonistsFiled 2003·Application pending·0 cites
Showing the top 50 of 78 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Albert Zlotnik files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →